XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 10 of 122 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. UCL engineering cancer antibody therapies for Covid-19 | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2020/jun/ucl-engineering-cancer-antibody-therapies-covid-19

    18 Jun 2020: A new project, led by Dr Martin Pule and Professor Kerry Chester will investigate repurposing a sophisticated antibody engineering approach to research and develop a new treatment against Covid-19.

    A new project, led by Dr Martin Pule and Professor Kerry Chester will investigate repurposing a sophisticated antibody engineering approach to research and develop a new treatment against Covid-19.

  2. COVID-19: Inside a Lighthouse Lab testing facility | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2020/jun/covid-19-inside-lighthouse-lab-testing-facility

    12 Jun 2020: During the pandemic, UCL has been providing support to the UK Lighthouse Labs COVID-19 diagnostic lab network. Cancer researcher, Dr Victoria Begley, shares her experience of volunteering at one of the Lighthouse Labs in Milton Keynes.

    During the pandemic, UCL has been providing support to the UK Lighthouse Labs COVID-19 diagnostic lab network. Cancer researcher, Dr Victoria Begley, shares her experience of volunteering at one of the Lighthouse Labs in Milton Keynes.

  3. UCL Education Awards 2020 | UCL Cancer Institute - UCL – University…

    https://www.ucl.ac.uk/cancer/news/2020/jun/ucl-education-awards-2020

    10 Jun 2020: Dr Adam Paige, Cancer Institute Graduate Tutor and Cancer MSc Programme Lead, has been awarded a Provost Education Award in the UCL Education Awards 2020. The awards recognise staff making outstanding contributions to the learning experience and

    Dr Adam Paige, Cancer Institute Graduate Tutor and Cancer MSc Programme Lead, has been awarded a Provost Education Award in the UCL Education Awards 2020. The awards recognise staff making outstanding contributions to the learning experience and

  4. Immunotherapy for bowel cancer could change clinical practice | UCL…

    https://www.ucl.ac.uk/cancer/news/2020/may/immunotherapy-bowel-cancer-could-change-clinical-practice

    29 May 2020: A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with

    A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with

  5. Cellular mechanism discovery offers potential treatment target for…

    https://www.ucl.ac.uk/cancer/news/2020/may/cellular-mechanism-discovery-offers-potential-treatment-target-high-risk-t-all

    14 May 2020: Researchers at UCL have discovered a novel cellular mechanism in a type of high-risk T-cell acute lymphoblastic leukaemia (T-ALL) that could be targeted with a checkpoint kinase inhibitor drug to help treat the disease.

    Researchers at UCL have discovered a novel cellular mechanism in a type of high-risk T-cell acute lymphoblastic leukaemia (T-ALL) that could be targeted with a checkpoint kinase inhibitor drug to help treat the disease.

  6. Professor Charles Swanton elected to AACR Fellowship | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2020/may/professor-charles-swanton-elected-aacr-fellowship

    12 May 2020: Renowned cancer researcher, Professor Swanton, joins prestigious group of leading scientists who have been recognised by the American Association of Cancer Research (AACR) for their scientific achievements in cancer research.

    Renowned cancer researcher, Professor Swanton, joins prestigious group of leading scientists who have been recognised by the American Association of Cancer Research (AACR) for their scientific achievements in cancer research.

  7. Trial to test immunosuppressant drug on COVID-19 pneumonia patients…

    https://www.ucl.ac.uk/cancer/news/2020/may/trial-test-immunosuppressant-drug-covid-19-pneumonia-patients-begins

    5 May 2020: Researchers in the COVACTA study led at UCLH by Dr Claire Roddie and Prof Kwee Yong will investigate whether tocilizumab can dampen the overactive immune response clinicians have observed in patients.

    Researchers in the COVACTA study led at UCLH by Dr Claire Roddie and Prof Kwee Yong will investigate whether tocilizumab can dampen the overactive immune response clinicians have observed in patients.

  8. More effective stem cell transplant method could aid blood cancer…

    https://www.ucl.ac.uk/cancer/news/2020/mar/more-effective-stem-cell-transplant-method-could-aid-blood-cancer-patients

    26 Mar 2020: Researchers at UCL have developed a new way to make the blood stem cells present in the umbilical cord ‘more transplantable’, a finding which could improve the treatment of a wide range of blood diseases in children and adults.

    Researchers at UCL have developed a new way to make the blood stem cells present in the umbilical cord ‘more transplantable’, a finding which could improve the treatment of a wide range of blood diseases in children and adults.

  9. Professor Bart Vanhaesebroeck to receive Excellence in Science award…

    https://www.ucl.ac.uk/cancer/news/2020/mar/professor-bart-vanhaesebroeck-receive-excellence-science-award

    24 Mar 2020: The Biochemical Society have announced that the 2021 Portland Press Excellence in Science Award will be presented to Professor Bart Vanhaesebroeck in recognition of his pioneering work on PI 3-kinase (PI3K) signalling enzymes.

    The Biochemical Society have announced that the 2021 Portland Press Excellence in Science Award will be presented to Professor Bart Vanhaesebroeck in recognition of his pioneering work on PI 3-kinase (PI3K) signalling enzymes.

  10. Cancer’s ‘genome doubling’ mystery solved | UCL Cancer Institute -…

    https://www.ucl.ac.uk/cancer/news/2020/mar/cancers-genome-doubling-mystery-solved

    10 Mar 2020: Researchers at the Crick and UCL have established why some cancer cells exhibit an unusual phenomenon called whole genome doubling, where every chromosome is duplicated.

    Researchers at the Crick and UCL have established why some cancer cells exhibit an unusual phenomenon called whole genome doubling, where every chromosome is duplicated.

Pagination

Refine

Subjects

Organisational Units

Communication types

Audiences